E. Sullivan

发表

Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis.

K. Brown, S. K. Frankel, E. Sullivan, 2002, Critical care clinics.

Lymphangioleiomyomatosis: a review.

E. Sullivan, Eugene J. Sullivan, 1998, Chest.

Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report.

M. Gladwin, R. Weinshilboum, M. Humbert, 2010, American journal of respiratory and critical care medicine.

Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil

M. Corboz, Zhili Li, D. Cipolla, 2020, ERJ Open Research.

Role of Tc-99m MIBI in the evaluation of single pulmonary nodules: a preliminary report

A. Mehta, A. Dasgupta, A. Arroliga, 2000, Thorax.

THE REGISTRY FOR INDIVIDUALS WITH LYMPHANGIOLEIOMYOMATOSIS

G. Beck, J. Stoller, E. Sullivan, 1999 .

Lymphangioleiomyomatosis: new insights.

G. Beck, J. Stoller, H. Peavy, 1997, American journal of respiratory and critical care medicine.

Serious asthma exacerbations in asthmatics treated with high-dose formoterol.

R. Nicklas, B. Chowdhury, M. Mann, 2003, Chest.

Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis.

J. Stoller, M. Kavuru, M. Thomassen, 2000, American journal of respiratory and critical care medicine.

Comments on the Salmeterol Multicenter Asthma Research Trial.

B. Chowdhury, E. Sullivan, S. Seymour, 2006, Chest.

Scout – sarcoidosis outcomes taskforce. A systematic review of outcomes to inform the development of a core outcome set for pulmonary sarcoidosis

P. Williamson, R. Baughman, J. Grutters, 2021, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Air travel in women with lymphangioleiomyomatosis

G. Downey, Simon R. Johnson, F. McCormack, 2006, Thorax.

Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.

J. Huggins, S. Sahn, J. Ryu, 2006, Chest.

Pulmonary vasculitis.

G. Hoffman, E. Sullivan, G. Hoffman, 1998, Clinics in chest medicine.

Recurrence and Lung Transplantation Complications Management of Pneumothorax in Lymphangioleiomyomatosis: Effects on

J. Huggins, S. Sahn, J. Ryu, 2006 .

Innovation in Clinical Trial Design and Product Promotion: Evolving the Patient Perspective With Regulatory and Technological Advances.

E. Sullivan, Mary L Raber-Johnson, Wolfgang E Gallwitz, 2019, Therapeutic innovation & regulatory science.

Report of workshop on lymphangioleiomyomatosis

M. Schluchter, G. Beck, S. Oparil, 1999 .

Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients.

R. Tiernan, E. Sullivan, Singer Sj, 2000, The New England journal of medicine.

Lymphangioleiomyomatosis Air travel in women with

G. Downey, Simon R. Johnson, F. McCormack, 2007 .

The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.

E. Henske, J. Ryu, J. Ryu, 2001, American journal of respiratory and critical care medicine.

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

J. Krischer, Hye-Seung Lee, L. Korbee, 2011, The New England journal of medicine.

Pulmonary involvement in Niemann-Pick disease: case report and literature review.

J. Stoller, O. Minai, E. Sullivan, 2000, Respiratory medicine.

Investigative bronchoprovocation and bronchoscopy in airway diseases.

W. Busse, M. Castro, S. Peters, 2005, American journal of respiratory and critical care medicine.

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

J. Brożek, J. D’Armiento, C. Strange, 2016, American journal of respiratory and critical care medicine.

Of ﬁ cial American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management

J. Brożek, C. Strange, S. Sahn, 2016 .

Of fi cial American Thoracic Society / Japanese Respiratory Society Clinical Practice Guidelines : Lymphangioleiomyomatosis Diagnosis and Management

J. Brożek, C. Strange, S. Sahn, 2016 .

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.

A. O'donnell, C. Daley, F. Blasi, 2020, The New England journal of medicine.

Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction.

P. Merkel, A. Arroliga, D. Vassilopoulos, 2003, Arthritis and rheumatism.

Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder

Zhili Li, V. Malinin, E. Sullivan, 2022, Frontiers in Drug Delivery.

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder

Zhili Li, V. Malinin, E. Sullivan, 2023, Pharmaceutics.

Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial

B. Korkmaz, J. Chalmers, D. Lasala, 2023, Respiratory Research.

Pulmonary Hypertension Resulting from Primary Pulmonary Amyloidosis

M. Schwarz, E. Sullivan, 1994 .